Main Conference Day Two
9:00 am - 9:45 am KEYNOTE: Streamlining the Process: Maximize Usability and Minimize Costs from Compounds to Biologics
9:45 am - 10:30 am PANEL DISCUSSION: The Extension of Your Lab: Building Best-Practices for CRO Partnership
Elizabeth Admirand - Principle Research Associate, Lead Discovery Epizyme
11:15 am - 12:00 pm CASE STUDY: The Evolution of Compounds Management at AstraZeneca Boston
Jeff Andrews - Senior Research Scientist AstraZenecaJeff Andrews
Senior Research ScientistAstraZeneca
12:00 pm - 12:45 pm Blending Compound, Biological, and Clinical Sample Storage
1:45 pm - 2:30 pm Integrating Automation and a High-Performance Team within a Compound Management Environment
Jefferson Chin - Analytical Chemist/Lab Manager Bristol-Myers Squibb
2:30 pm - 3:15 pm Fostering Pre-Competitive Partnerships with Big Pharma and Biobanks to Further Sequencing Efforts
8:00 am - 12:00 am ROUNDTABLE DISCUSSIONS: Join the conversation with your peers on the hottest topics in the industry!
TABLE 1:
Leading Through Change and Organizational Restructuring
Discuss how to build a cohesive, agile team capable of performing during organizational shifts
Focus on the institutional knowledge, retention, ROI, and culture, of both contract staff and company staff
TABLE 2:
The Lab Of The Future
Employ principles of lean six sigma to assist in reducing non-value-added work from a process level—in lab design
TABLE 3:
Data Curation
How accurate is your data? Have you performed an audit?
Learn the true quality of your data—prior to upgrading your systems
